Loading…
In vitro and in vivo biocompatibility, bioavailability and tolerance of an injectable vehicle for adipose-derived stem/stromal cells for plastic surgery indications
Summary Soft tissue reconstruction is a challenge in plastic surgery, when replacing lost materials and correcting contour defects. Many permanent and temporary fillers have been used to restore the volume of these lesions, but often with poor results and even complications. Adipose-derived stem/str...
Saved in:
Published in: | Journal of plastic, reconstructive & aesthetic surgery reconstructive & aesthetic surgery, 2015-11, Vol.68 (11), p.1491-1497 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Summary Soft tissue reconstruction is a challenge in plastic surgery, when replacing lost materials and correcting contour defects. Many permanent and temporary fillers have been used to restore the volume of these lesions, but often with poor results and even complications. Adipose-derived stem/stromal cells (ASCs) and adipose tissue engineering have been suggested as valuable alternatives. In order to inject these cultured cells, it was essential to find a suitable vehicle. The purpose of this study was to evaluate Cytocare® , an injectable medical device, composed of hyaluronic acid plus amino acids, vitamins and mineral salts. First, ASC viability and bioavailability in the 3 different available Cytocare® formulations using the MTT test were assessed; then an animal experiment, testing the tolerance after intradermal injections of both Cytocare® alone and with ASCs was carried out. Our in vitro results demonstrate a high biocompatibility of Cytocare® resulting in a better viability of ASCs when cultured in Cytocare® compared to culture medium (p |
---|---|
ISSN: | 1748-6815 1878-0539 |
DOI: | 10.1016/j.bjps.2015.07.022 |